HOXA10 and neoplasm: In vivo and in vitro studies have shown that HOXA10-AS induces OSCC malignant behavior by the promotion of OSCC cell proliferation, migration, invasion, stemness, tumor growth, and metastasis (Yan et al., 2020; Wang, 2021; Chen et al., 2022).